| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |